| dc.contributor.author | Wolff, A. | |
| dc.contributor.author | Lazar, A. | |
| dc.contributor.author | Bondarenko, I. | |
| dc.contributor.author | Garin, A. | |
| dc.contributor.author | Brincat, S. | |
| dc.contributor.author | Chow, L. | |
| dc.contributor.author | Sun, Y. | |
| dc.contributor.author | Neskovic-Konstantinovic, Z. | |
| dc.contributor.author | Guimaraes, R. | |
| dc.contributor.author | Fumoleau, P. | |
| dc.contributor.author | Chan, Arlene | |
| dc.contributor.author | Hachemi, S. | |
| dc.contributor.author | Strahs, A. | |
| dc.contributor.author | Cincotta, M. | |
| dc.contributor.author | Berkenblit, A. | |
| dc.contributor.author | Krygowski, M. | |
| dc.contributor.author | Kang, L.L. | |
| dc.contributor.author | Moore, L. | |
| dc.contributor.author | Hayes, D. | |
| dc.date.accessioned | 2017-01-30T12:58:51Z | |
| dc.date.available | 2017-01-30T12:58:51Z | |
| dc.date.created | 2014-11-19T01:13:19Z | |
| dc.date.issued | 2013 | |
| dc.identifier.citation | Wolff, A. and Lazar, A. and Bondarenko, I. and Garin, A. and Brincat, S. and Chow, L. and Sun, Y. et al. 2013. Randomized Phase 111 Placebo-Controlled Trial of Letrozole Plus Oral Temsirolimus As First-Line Endrocrine Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer. Journal of Clinical Oncology. 31 (2): pp. 195-202. | |
| dc.identifier.uri | http://hdl.handle.net/20.500.11937/27423 | |
| dc.publisher | American Society of Clinical Oncology | |
| dc.title | Randomized Phase 111 Placebo-Controlled Trial of Letrozole Plus Oral Temsirolimus As First-Line Endrocrine Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer | |
| dc.type | Journal Article | |
| dcterms.source.volume | 31 | |
| dcterms.source.number | 2 | |
| dcterms.source.startPage | 195 | |
| dcterms.source.endPage | 202 | |
| dcterms.source.issn | 0732 183X | |
| dcterms.source.title | Journal of Clinical Oncology | |
| curtin.accessStatus | Fulltext not available | |
